hotspot -WSS

hotspot

author：explore 2025-10-02 11:08:13 - browse：46772

Aerial photograph of Austin, Texas — Austin, Texas has become the grounds for dueling powerful interests fighting over health care services for poor patients. Brandon Bell/Getty Images

AUSTIN, Texas — The partnership between one of the nation’s largest Catholic health systems and a local government agency focused on caring for poor patients was supposed to be mutually beneficial for everyone involved. But it didn’t quite turn out that way.

The alliance in theory meant that Travis County, home to the growing metro area of Austin, could provide more care to low-income patients cheaper than other big cities in the state. And Ascension, a not-for-profit behemoth, would get to own a brand-new teaching hospital and work with an elite new medical school at the University of Texas at Austin.

But two decades after the agency and Ascension first came together in the name of providing care for poor patients, their relationship has almost completely unraveled.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Cano Health’s bankruptcy is a warning for Medicare Advantage

leisure time

WSS

Why Novartis is going to walk from its acquisition of MorphoSys

Free speech concerns arise in wake of journal editor Eisen's firing

Medicare solvency divides Republicans at the presidential debate

AI gets buy

Global cancer cases to surge 77% by 2050, WHO report says

Will General Catalyst be the first of many hospital takeovers?

leisure time

hotspot

hotspot

Apple is now the first public company to be valued at $3 trillion

AI gets buy

23andMe had bad news about my health. I wish a person had delivered it

Will General Catalyst be the first of many hospital takeovers?

As demand for Covid shots wanes, Moderna seeks its next success

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

United colonoscopy coverage change 'may cost lives,' doctors say

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Cancer drug shortages should be causing more outrage

Ambulance rides for just $100? Advisers want major billing fixes

explore

Adopting new red light myopia treatments may be short

Why Novartis is going to walk from its acquisition of MorphoSys

AstraZeneca stays mum on Medicare drug pricing negotiations

FDA approves potent Eli Lilly obesity drug, Zepbound

MoonLake credibility takes another hit with mid

A protest over insulin prices is seen as a fight for life

hotspot

leisure time

leisure time

explore